Advances in treatment of systemic sclerosis

Lancet. 1998 Dec 12;352(9144):1874-5. doi: 10.1016/S0140-6736(05)60391-1.
No abstract available

MeSH terms

  • Cyclophosphamide / therapeutic use
  • Epoprostenol / therapeutic use
  • Humans
  • Iloprost / therapeutic use
  • Interferon-alpha / therapeutic use
  • Scleroderma, Systemic / therapy*

Substances

  • Interferon-alpha
  • Cyclophosphamide
  • Epoprostenol
  • Iloprost